Farmakologiia i toksikologiia 1991-01-01

[The clinical pharmacokinetics of kemantane].

S S Boĭko, V P Zherdev, N A Kisliak

Index: Farmakol. Toksikol. 54(1) , 57-9, (1991)

Full Text: HTML

Abstract

The pharmacokinetics of a new Soviet-made immunostimulant kemantane, a derivative of adamantine, was studied by gas-liquid chromatography in patients with bronchial pathology. It was found that in the blood of the patients kemantane was not practically detected due to a pronounced effect of the "first pass" through the liver. Kemantane kinetics was evaluated by the kinetics of its major active metabolite. On the basis of the performed studies the scheme of using kemantane in the patients with decreased immunity was recommended.


Related Compounds

Related Articles:

[Interspecific differences in kemantan pharmacokinetics].

1994-01-01

[Eksp. Klin. Farmakol. 57(6) , 48-50, (1994)]

[Kemantane pharmacokinetics in rats].

1990-11-01

[Biull. Eksp. Biol. Med. 110(11) , 501-3, (1990)]

[Treatment of immunodeficient conditions caused by viral infection with the Soviet immunomodulator kemantan in patients with pulmonary tuberculosis].

1991-01-01

[Probl. Tuberk. (6) , 23-6, (1991)]

Effect of adamantanone derivative possessing anti-HIV properties on the redox processes in the cytochrome P-450 system.

2001-01-01

[Dokl. Biochem. Biophys. 378 , 210-3, (2001)]

[The effect of kemantane on T-helpers and T-suppressors].

1991-09-01

[Zh. Mikrobiol. Epidemiol. Immunobiol. (9) , 66-7, (1991)]

More Articles...